Zeheng Lv

P.R. China
Shanghai, 200092, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Correction: mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3IBTK-mediated ubiquitination of eIF4A1 in cancer cells.

Correction: mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3IBTK-mediated ubiquitination of eIF4A1 in cancer cells.

Journal: eLife

Published: June 17, 2026

FBXW7 mutations reprogram glucose metabolism by activating the ETV6-GLUT1 axis.

FBXW7 mutations reprogram glucose metabolism by activating the ETV6-GLUT1 axis.

Journal: Molecular cancer

Published: July 14, 2025

Erratum: SPOP targets oncogenic protein ZBTB3 for destruction to suppress endometrial cancer.

Erratum: SPOP targets oncogenic protein ZBTB3 for destruction to suppress endometrial cancer.

Journal: American journal of cancer research

Published: May 26, 2025

Editorial Expression of Concern: DCAF12 promotes apoptosis and inhibits NF-κB activation by acting as an endogenous antagonist of IAPs.

Editorial Expression of Concern: DCAF12 promotes apoptosis and inhibits NF-κB activation by acting as an endogenous antagonist of IAPs.

Journal: Oncogene

Published: December 13, 2024

mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3IBTK-mediated ubiquitination of eIF4A1 in cancer cells.

mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3IBTK-mediated ubiquitination of eIF4A1 in cancer cells.

Journal: eLife

Published: May 13, 2024

RBM10 suppresses malignant transformation in endometrial cancer via the Hippo-YAP signaling pathway.

RBM10 suppresses malignant transformation in endometrial cancer via the Hippo-YAP signaling pathway.

Journal: American journal of translational research

Published: March 19, 2024

Erratum: SPOP targets oncogenic protein ZBTB3 for destruction to suppress endometrial cancer.

Erratum: SPOP targets oncogenic protein ZBTB3 for destruction to suppress endometrial cancer.

Journal: American journal of cancer research

Published: October 19, 2023

Phosphorylation of INF2 by AMPK promotes mitochondrial fission and oncogenic function in endometrial cancer.

Phosphorylation of INF2 by AMPK promotes mitochondrial fission and oncogenic function in endometrial cancer.

Journal: Cell death & disease

Published: August 11, 2023

JAK1 inactivation promotes proliferation and migration of endometrial cancer cells via upregulating the hypoxia-inducible factor signaling pathway.

JAK1 inactivation promotes proliferation and migration of endometrial cancer cells via upregulating the hypoxia-inducible factor signaling pathway.

Journal: Cell communication and signaling : CCS

Published: August 14, 2022

Therapeutic exosomes loaded with SERPINA5 attenuated endometrial cancer cell migration via the integrin β1/FAK signaling pathway.

Therapeutic exosomes loaded with SERPINA5 attenuated endometrial cancer cell migration via the integrin β1/FAK signaling pathway.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: June 20, 2022

SPOP mutations promote tumor immune escape in endometrial cancer via the IRF1-PD-L1 axis.

SPOP mutations promote tumor immune escape in endometrial cancer via the IRF1-PD-L1 axis.

Journal: Cell death and differentiation

Published: March 15, 2022

DCAF12 promotes apoptosis and inhibits NF-κB activation by acting as an endogenous antagonist of IAPs.

DCAF12 promotes apoptosis and inhibits NF-κB activation by acting as an endogenous antagonist of IAPs.

Journal: Oncogene

Published: November 16, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026